Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,726 | 83 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $236.41 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $215.79 | 12 | $0 (2024) |
| HEARTFLOW, INC. | $171.86 | 2 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $155.90 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $144.62 | 7 | $0 (2024) |
| Boston Scientific Corporation | $132.36 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $123.90 | 7 | $0 (2023) |
| PFIZER INC. | $102.80 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $85.85 | 5 | $0 (2024) |
| Abbott Laboratories | $75.72 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $623.38 | 26 | HEARTFLOW, INC. ($157.15) |
| 2023 | $796.98 | 40 | Novartis Pharmaceuticals Corporation ($152.73) |
| 2022 | $305.19 | 17 | AstraZeneca Pharmaceuticals LP ($88.76) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: DIABETES | ||||||
| 10/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Genetic Disease | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: DIABETES | ||||||
| 08/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/14/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $157.15 | General |
| Category: Coronary | ||||||
| 06/12/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $33.19 | General |
| Category: Genetic Disease | ||||||
| 05/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Not Applicable | ||||||
| 04/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiology | ||||||
| 04/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Cardiology | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.83 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Cardiology | ||||||
| 01/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.90 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 286 | 304 | $31,466 | $11,346 |
| 2022 | 5 | 265 | 275 | $26,200 | $10,882 |
| 2021 | 6 | 278 | 296 | $25,432 | $10,335 |
| 2020 | 6 | 310 | 343 | $39,722 | $15,329 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 75 | $13,665 | $5,235 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 91 | $11,669 | $4,394 | 37.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 26 | $1,872 | $813.74 | 43.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 65 | 68 | $2,720 | $531.00 | 19.5% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 43 | 44 | $1,540 | $371.78 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 70 | $11,410 | $5,001 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 80 | $9,116 | $4,212 | 46.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 29 | 29 | $2,064 | $900.34 | 43.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 50 | 50 | $2,000 | $403.29 | 20.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 45 | 46 | $1,610 | $364.95 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 54 | $8,802 | $3,774 | 42.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 62 | $6,758 | $3,294 | 48.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 51 | 54 | $3,564 | $1,654 | 46.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 21 | 22 | $2,398 | $776.69 | 32.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 49 | 54 | $2,160 | $480.35 | 22.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 48 | 50 | $1,750 | $355.68 | 20.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 66 | 76 | $12,388 | $4,315 | 34.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 73 | 78 | $8,502 | $3,545 | 41.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 74 | $8,066 | $3,223 | 40.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 39 | 44 | $7,172 | $3,028 | 42.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 29 | 29 | $1,914 | $799.27 | 41.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 34 | 42 | $1,680 | $418.74 | 24.9% |
About Linda Marquez, NP
Linda Marquez, NP is a Registered Nurse healthcare provider based in Danville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2017. The National Provider Identifier (NPI) number assigned to this provider is 1952827529.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Linda Marquez, NP has received a total of $1,726 in payments from pharmaceutical and medical device companies, with $623.38 received in 2024. These payments were reported across 83 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,726).
As a Medicare-enrolled provider, Marquez has provided services to 1,139 Medicare beneficiaries, totaling 1,218 services with total Medicare billing of $47,891. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Danville, IN
- Active Since 08/16/2017
- Last Updated 06/14/2021
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1952827529
Products in Payments
- Repatha (Biological) $236.41
- LEQVIO (Drug) $215.79
- FFRct (Device) $171.86
- LifeVest (Device) $155.90
- JARDIANCE (Drug) $144.62
- FARXIGA (Drug) $86.46
- VERQUVO (Drug) $85.85
- WATCHMAN FLX (Device) $82.35
- ONPATTRO (Drug) $62.84
- VYNDAQEL (Drug) $60.75
- ELIQUIS (Drug) $57.48
- WATCHMAN Access System (Device) $50.01
- BRILINTA (Drug) $37.44
- Inpefa (Drug) $29.69
- XIENCE V (Device) $29.65
- AVEIR (Device) $29.10
- CAMZYOS (Drug) $27.90
- HAWKONE (Device) $27.15
- Arcalyst (Drug) $21.07
- FUROSCIX (Drug) $17.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Danville
Lisa Faer
Registered Nurse — Payments: $67,905
Mrs. Kathryn Furge, Fnp-B, FNP-B
Registered Nurse — Payments: $7,624
Mr. Beau Semler, Np, NP
Registered Nurse — Payments: $5,059
Mrs. Rachel Devaney, Rn, RN
Registered Nurse — Payments: $1,096
Mindy Vlacich, Crnp, CRNP
Registered Nurse — Payments: $441.25
Kathryn Levoy, Fnp-C, FNP-C
Registered Nurse — Payments: $388.52